APO Research
Talk to an analyst

APO RESEARCH · REPORT

Endorphins

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Endorphins Industry Growth and Trends Forecast to 2032

31 December 202596 pages

Choose your research edition.

Industry ResearchEndorphins Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Endorphins Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Endorphins Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endorphins Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Endorphins Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Endorphins market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Endorphins is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Endorphins is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Endorphins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Endorphins include Assertio Therapeutics Inc., Cipher Pharmaceuticals Inc., Egalet Corp., Endo International Plc, Lannett Co. Inc., Pfizer and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Endorphins market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Endorphins market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Endorphins market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Endorphins.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Endorphins market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Endorphins Market by Company

Assertio Therapeutics Inc.

Cipher Pharmaceuticals Inc.

Egalet Corp.

Endo International Plc

Lannett Co. Inc.

Pfizer

Johnson & Johnson

Endorphins Segment by Type

Sigma-Endorphins

Gamma-Endorphins

Beta-Endorphins

Alpha-Endorphins

Endorphins Segment by Application

Institutional Pharmacies

Retail Pharmacies

Online Pharmacies

Endorphins Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endorphins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endorphins and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endorphins.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Endorphins manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Endorphins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Sigma-Endorphins Table 2. Major Company of Gamma-Endorphins Table 3. Major Company of Beta-Endorphins Table 4. Major Company of Alpha-Endorphins Table 5. Global Endorphins Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Endorphins Sales by Type (2021-2026) & (K Units) Table 7. Global Endorphins Sales Market Share in Volume by Type (2021-2026) Table 8. Global Endorphins Sales by Type (2021-2026) & (US$ Million) Table 9. Global Endorphins Sales Market Share in Value by Type (2021-2026) Table 10. Global Endorphins Price by Type (2021-2026) & (US$/Unit) Table 11. Global Endorphins Sales by Type (2027-2032) & (K Units) Table 12. Global Endorphins Sales Market Share in Volume by Type (2027-2032) Table 13. Global Endorphins Sales by Type (2027-2032) & (US$ Million) Table 14. Global Endorphins Sales Market Share in Value by Type (2027-2032) Table 15. Global Endorphins Price by Type (2027-2032) & (US$/Unit) Table 16. North America Endorphins Sales by Type (2021-2026) & (K Units) Table 17. North America Endorphins Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Endorphins Sales by Type (2021-2026) & (K Units) Table 19. Europe Endorphins Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Endorphins Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Endorphins Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Endorphins Sales by Type (2021-2026) & (K Units) Table 23. Latin America Endorphins Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Endorphins Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Endorphins Sales by Type (2021-2026) & (US$ Million) Table 26. Endorphins Industry Trends Table 27. Endorphins Industry Drivers Table 28. Endorphins Industry Opportunities and Challenges Table 29. Endorphins Industry Restraints Table 30. Global Endorphins Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Endorphins Revenue Market Share by Company (2021-2026) Table 32. Global Endorphins Sales by Company (2021-2026) & (K Units) Table 33. Global Endorphins Sales Share by Company (2021-2026) Table 34. Global Endorphins Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Endorphins Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Endorphins Major Company Production Sites and Headquarters Table 37. Global Endorphins Company, Product Type & Application Table 38. Global Endorphins Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Endorphins by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Endorphins Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Endorphins Sales by Region (2021-2026) & (K Units) Table 43. Global Endorphins Sales Market Share in Volume by Region (2021-2026) Table 44. Global Endorphins Sales by Region (2021-2026) & (US$ Million) Table 45. Global Endorphins Sales Market Share in Value by Region (2021-2026) Table 46. Global Endorphins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Endorphins Sales by Region (2027-2032) & (K Units) Table 48. Global Endorphins Sales Market Share in Volume by Region (2027-2032) Table 49. Global Endorphins Sales by Region (2027-2032) & (US$ Million) Table 50. Global Endorphins Sales Market Share in Value by Region (2027-2032) Table 51. Global Endorphins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Endorphins Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Endorphins Sales by Application (2021-2026) & (K Units) Table 54. Global Endorphins Sales Market Share in Volume by Application (2021-2026) Table 55. Global Endorphins Sales by Application (2021-2026) & (US$ Million) Table 56. Global Endorphins Sales Market Share in Value by Application (2021-2026) Table 57. Global Endorphins Price by Application (2021-2026) & (US$/Unit) Table 58. Global Endorphins Sales by Application (2027-2032) & (K Units) Table 59. Global Endorphins Sales Market Share in Volume by Application (2027-2032) Table 60. Global Endorphins Sales by Application (2027-2032) & (US$ Million) Table 61. Global Endorphins Sales Market Share in Value by Application (2027-2032) Table 62. Global Endorphins Price by Application (2027-2032) & (US$/Unit) Table 63. North America Endorphins Sales by Application (2021-2026) & (K Units) Table 64. North America Endorphins Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Endorphins Sales by Application (2021-2026) & (K Units) Table 66. Europe Endorphins Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Endorphins Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Endorphins Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Endorphins Sales by Application (2021-2026) & (K Units) Table 70. Latin America Endorphins Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Endorphins Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Endorphins Sales by Application (2021-2026) & (US$ Million) Table 73. Assertio Therapeutics Inc. Company Information Table 74. Assertio Therapeutics Inc. Business Overview Table 75. Assertio Therapeutics Inc. Endorphins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Assertio Therapeutics Inc. Endorphins Product Portfolio Table 77. Assertio Therapeutics Inc. Recent Development Table 78. Cipher Pharmaceuticals Inc. Company Information Table 79. Cipher Pharmaceuticals Inc. Business Overview Table 80. Cipher Pharmaceuticals Inc. Endorphins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Cipher Pharmaceuticals Inc. Endorphins Product Portfolio Table 82. Cipher Pharmaceuticals Inc. Recent Development Table 83. Egalet Corp. Company Information Table 84. Egalet Corp. Business Overview Table 85. Egalet Corp. Endorphins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Egalet Corp. Endorphins Product Portfolio Table 87. Egalet Corp. Recent Development Table 88. Endo International Plc Company Information Table 89. Endo International Plc Business Overview Table 90. Endo International Plc Endorphins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Endo International Plc Endorphins Product Portfolio Table 92. Endo International Plc Recent Development Table 93. Lannett Co. Inc. Company Information Table 94. Lannett Co. Inc. Business Overview Table 95. Lannett Co. Inc. Endorphins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Lannett Co. Inc. Endorphins Product Portfolio Table 97. Lannett Co. Inc. Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Endorphins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Pfizer Endorphins Product Portfolio Table 102. Pfizer Recent Development Table 103. Johnson & Johnson Company Information Table 104. Johnson & Johnson Business Overview Table 105. Johnson & Johnson Endorphins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Johnson & Johnson Endorphins Product Portfolio Table 107. Johnson & Johnson Recent Development Table 108. North America Endorphins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 109. North America Endorphins Sales by Country (2021-2026) & (K Units) Table 110. North America Endorphins Sales Market Share by Country (2021-2026) Table 111. North America Endorphins Sales Forecast by Country (2027-2032) & (K Units) Table 112. North America Endorphins Sales Market Share Forecast by Country (2027-2032) Table 113. North America Endorphins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Endorphins Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Endorphins Market Share by Country (2021-2026) Table 116. North America Endorphins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Endorphins Market Share Forecast by Country (2027-2032) Table 118. Europe Endorphins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. Europe Endorphins Sales by Country (2021-2026) & (K Units) Table 120. Europe Endorphins Sales Market Share by Country (2021-2026) Table 121. Europe Endorphins Sales Forecast by Country (2027-2032) & (K Units) Table 122. Europe Endorphins Sales Market Share Forecast by Country (2027-2032) Table 123. Europe Endorphins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Endorphins Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Endorphins Market Share by Country (2021-2026) Table 126. Europe Endorphins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Endorphins Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Endorphins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Endorphins Sales by Country (2021-2026) & (K Units) Table 130. Asia-Pacific Endorphins Sales Market Share by Country (2021-2026) Table 131. Asia-Pacific Endorphins Sales Forecast by Country (2027-2032) & (K Units) Table 132. Asia-Pacific Endorphins Sales Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Endorphins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Endorphins Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Endorphins Market Share by Country (2021-2026) Table 136. Asia-Pacific Endorphins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Endorphins Market Share Forecast by Country (2027-2032) Table 138. Latin America Endorphins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Latin America Endorphins Sales by Country (2021-2026) & (K Units) Table 140. Latin America Endorphins Sales Market Share by Country (2021-2026) Table 141. Latin America Endorphins Sales Forecast by Country (2027-2032) & (K Units) Table 142. Latin America Endorphins Sales Market Share Forecast by Country (2027-2032) Table 143. Latin America Endorphins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Endorphins Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Endorphins Market Share by Country (2021-2026) Table 146. Latin America Endorphins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Endorphins Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Endorphins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Endorphins Sales by Country (2021-2026) & (K Units) Table 150. Middle East and Africa Endorphins Sales Market Share by Country (2021-2026) Table 151. Middle East and Africa Endorphins Sales Forecast by Country (2027-2032) & (K Units) Table 152. Middle East and Africa Endorphins Sales Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Endorphins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Endorphins Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East and Africa Endorphins Market Share by Country (2021-2026) Table 156. Middle East and Africa Endorphins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Endorphins Market Share Forecast by Country (2027-2032) Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. Endorphins Distributors List Table 161. Endorphins Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Endorphins Image Figure 2. Global Endorphins Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endorphins Market Size (2021-2032) & (US$ Million) Figure 4. Global Endorphins Sales (2021-2032) & (K Units) Figure 5. Sigma-Endorphins Image Figure 6. Global Sigma-Endorphins Sales YoY Growth (2021-2032) & (K Units) Figure 7. Gamma-Endorphins Image Figure 8. Global Gamma-Endorphins Sales YoY Growth (2021-2032) & (K Units) Figure 9. Beta-Endorphins Image Figure 10. Global Beta-Endorphins Sales YoY Growth (2021-2032) & (K Units) Figure 11. Alpha-Endorphins Image Figure 12. Global Alpha-Endorphins Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Endorphins Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Endorphins Market Share by Type 2025 VS 2032 Figure 15. North America Endorphins Sales Market Share in Volume by Type in 2025 Figure 16. North America Endorphins Sales Market Share in Value by Type in 2025 Figure 17. Europe Endorphins Sales Market Share in Volume by Type in 2025 Figure 18. Europe Endorphins Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Endorphins Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Endorphins Sales Market Share in Value by Type in 2025 Figure 21. Latin America Endorphins Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Endorphins Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Endorphins Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Endorphins Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Endorphins Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Institutional Pharmacies Image Figure 28. Global Institutional Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 29. Retail Pharmacies Image Figure 30. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 31. Online Pharmacies Image Figure 32. Global Online Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Endorphins Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Endorphins Market Share by Application 2025 VS 2032 Figure 35. North America Endorphins Sales Market Share in Volume by Application in 2025 Figure 36. North America Endorphins Sales Market Share in Value by Application in 2025 Figure 37. Europe Endorphins Sales Market Share in Volume by Application in 2025 Figure 38. Europe Endorphins Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Endorphins Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Endorphins Sales Market Share in Value by Application in 2025 Figure 41. Latin America Endorphins Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Endorphins Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Endorphins Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Endorphins Sales Market Share in Value by Application in 2025 Figure 45. North America Endorphins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Endorphins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Endorphins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Endorphins Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Endorphins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Endorphins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Endorphins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Endorphins Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Endorphins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Endorphins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Endorphins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Endorphins Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Endorphins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Endorphins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Endorphins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Endorphins Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Endorphins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Endorphins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Endorphins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Endorphins Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Endorphins Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Endorphins Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Sigma-Endorphins
  • Gamma-Endorphins
  • Beta-Endorphins
  • Alpha-Endorphins
Applications
  • Institutional Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Companies covered
  • Assertio Therapeutics Inc.
  • Cipher Pharmaceuticals Inc.
  • Egalet Corp.
  • Endo International Plc
  • Lannett Co. Inc.
  • Pfizer
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Endorphins Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Endorphins Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Endorphins Market by Type
  6. 1.3.1 Sigma-Endorphins
  7. 1.3.2 Gamma-Endorphins
  8. 1.3.3 Beta-Endorphins
  9. 1.3.4 Alpha-Endorphins
  10. 1.4 Global Endorphins Market Size by Type
  11. 1.4.1 Global Endorphins Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Endorphins Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Endorphins Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Endorphins Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Endorphins Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Endorphins Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Endorphins Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Endorphins Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Endorphins Industry Trends
  2. 2.2 Endorphins Industry Drivers
  3. 2.3 Endorphins Industry Opportunities and Challenges
  4. 2.4 Endorphins Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Endorphins Revenue (2021-2026)
  2. 3.2 Global Top Players by Endorphins Sales (2021-2026)
  3. 3.3 Global Top Players by Endorphins Price (2021-2026)
  4. 3.4 Global Endorphins Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Endorphins Major Company Production Sites & Headquarters
  6. 3.6 Global Endorphins Company, Product Type & Application
  7. 3.7 Global Endorphins Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Endorphins Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Endorphins Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Endorphins Tier 1, Tier 2, and Tier 3
4 Endorphins Regional Status and Outlook
  1. 4.1 Global Endorphins Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Endorphins Historic Market Size by Region
  3. 4.2.1 Global Endorphins Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Endorphins Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Endorphins Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Endorphins Forecasted Market Size by Region
  7. 4.3.1 Global Endorphins Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Endorphins Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Endorphins Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Endorphins by Application
  1. 5.1 Endorphins Market by Application
  2. 5.1.1 Institutional Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Online Pharmacies
  5. 5.2 Global Endorphins Market Size by Application
  6. 5.2.1 Global Endorphins Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Endorphins Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Endorphins Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Endorphins Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Endorphins Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Endorphins Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Endorphins Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Endorphins Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Assertio Therapeutics Inc.
  2. 6.1.1 Assertio Therapeutics Inc. Company Information
  3. 6.1.2 Assertio Therapeutics Inc. Business Overview
  4. 6.1.3 Assertio Therapeutics Inc. Endorphins Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Assertio Therapeutics Inc. Endorphins Product Portfolio
  6. 6.1.5 Assertio Therapeutics Inc. Recent Developments
  7. 6.2 Cipher Pharmaceuticals Inc.
  8. 6.2.1 Cipher Pharmaceuticals Inc. Company Information
  9. 6.2.2 Cipher Pharmaceuticals Inc. Business Overview
  10. 6.2.3 Cipher Pharmaceuticals Inc. Endorphins Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cipher Pharmaceuticals Inc. Endorphins Product Portfolio
  12. 6.2.5 Cipher Pharmaceuticals Inc. Recent Developments
  13. 6.3 Egalet Corp.
  14. 6.3.1 Egalet Corp. Company Information
  15. 6.3.2 Egalet Corp. Business Overview
  16. 6.3.3 Egalet Corp. Endorphins Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Egalet Corp. Endorphins Product Portfolio
  18. 6.3.5 Egalet Corp. Recent Developments
  19. 6.4 Endo International Plc
  20. 6.4.1 Endo International Plc Company Information
  21. 6.4.2 Endo International Plc Business Overview
  22. 6.4.3 Endo International Plc Endorphins Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Endo International Plc Endorphins Product Portfolio
  24. 6.4.5 Endo International Plc Recent Developments
  25. 6.5 Lannett Co. Inc.
  26. 6.5.1 Lannett Co. Inc. Company Information
  27. 6.5.2 Lannett Co. Inc. Business Overview
  28. 6.5.3 Lannett Co. Inc. Endorphins Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lannett Co. Inc. Endorphins Product Portfolio
  30. 6.5.5 Lannett Co. Inc. Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Endorphins Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Endorphins Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Johnson & Johnson
  38. 6.7.1 Johnson & Johnson Company Information
  39. 6.7.2 Johnson & Johnson Business Overview
  40. 6.7.3 Johnson & Johnson Endorphins Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Johnson & Johnson Endorphins Product Portfolio
  42. 6.7.5 Johnson & Johnson Recent Developments
7 North America by Country
  1. 7.1 North America Endorphins Sales by Country
  2. 7.1.1 North America Endorphins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Endorphins Sales by Country (2021-2026)
  4. 7.1.3 North America Endorphins Sales Forecast by Country (2027-2032)
  5. 7.2 North America Endorphins Market Size by Country
  6. 7.2.1 North America Endorphins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Endorphins Market Size by Country (2021-2026)
  8. 7.2.3 North America Endorphins Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Endorphins Sales by Country
  2. 8.1.1 Europe Endorphins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Endorphins Sales by Country (2021-2026)
  4. 8.1.3 Europe Endorphins Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Endorphins Market Size by Country
  6. 8.2.1 Europe Endorphins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Endorphins Market Size by Country (2021-2026)
  8. 8.2.3 Europe Endorphins Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Endorphins Sales by Country
  2. 9.1.1 Asia-Pacific Endorphins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Endorphins Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Endorphins Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Endorphins Market Size by Country
  6. 9.2.1 Asia-Pacific Endorphins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Endorphins Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Endorphins Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Endorphins Sales by Country
  2. 10.1.1 South America Endorphins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Endorphins Sales by Country (2021-2026)
  4. 10.1.3 South America Endorphins Sales Forecast by Country (2027-2032)
  5. 10.2 South America Endorphins Market Size by Country
  6. 10.2.1 South America Endorphins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Endorphins Market Size by Country (2021-2026)
  8. 10.2.3 South America Endorphins Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Endorphins Sales by Country
  2. 11.1.1 Middle East and Africa Endorphins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Endorphins Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Endorphins Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Endorphins Market Size by Country
  6. 11.2.1 Middle East and Africa Endorphins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Endorphins Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Endorphins Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Endorphins Value Chain Analysis
  2. 12.1.1 Endorphins Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Endorphins Production Mode & Process
  7. 12.2 Endorphins Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Endorphins Distributors
  10. 12.2.3 Endorphins Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst